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ABSTRACT  The  effects of the n-alkyl  derivatives of guanidine on  the  frog 
neuromuscular junction  were  studied  using  the  two-microelectrode  voltage 
clamp and other eleetrophysiological  techniques. Methyl-, ethyl-, and propyl- 
guanidine stimulated the nerve-evoked  release of transmitter. However, amyl- 
and octylguanidine had no apparent presynaptic action. All of the derivatives 
blocked the postsynaptic response to acetylcholine, the potency sequence being 
octyl- > amyl- > propyl-, methyl- > ethylguanidine.  Methyl- and octylguanidine 
did not protect the receptor from a-bungarotoxin block, suggesting that these 
compounds do not bind to the receptor but probably block the ionic channel. 
Methyl-, ethyl-, and propylguanidine shortened inward endplate currents but 
prolonged outward currents. Amylguanidine prolonged both inward and out- 
ward endplate currents, and the currents became biphasic at negative membrane 
potentials. Octylguanidine increased  the rate of decay of endplate currents at 
all  potentials.  All  of the derivatives blocked inward endplate currents more 
markedly than outward currents, resulting in a highly nonlinear current-voltage 
relation. Methyl-, ethyl-, and propylguanidine reversed the voltage dependence 
of endplate current decay, while amyl- and octylguanidine reduced the voltage 
dependence of endplate current  decay. Octylguanidine appears  to block the 
ionic  channel in both the open and the closed  state. The block of the open 
channel follows pseudo-first-order kinetics with a forward rate constant of 4-6 
￿  107 M -1 s-1. 
INTRODUCTION 
A variety of compounds have been proposed to interact with ionic channels of 
endplate  membranes.  Neher  and  Steinbach  (1978)  have  recorded  single- 
channel currents from endplate membranes and concluded that two quater- 
nary derivatives of lidocaine, QX-222  and QX-314, block the ionic channels 
when they are open. It has been proposed that decamethonium and amanta- 
dine also interact with the open channel (Adams and Sakmann, 1978;  Tsai et 
al.,  1978).  Procaine, barbiturates, histrionicotoxin (HTX), and tetraethylam- 
monium (TEA) appear to interact with the closed as well as the open channel 
(Adams,  1976,  1977;  Masukawa and Albuquerque,  1978;  Adler et al.,  1979). 
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Gage (1978)  has suggested that  another  group of compounds, the long-chain 
alcohols, modify the kinetics of channel closing by affecting the fluidity of the 
membrane. 
The n-alkyl derivatives of guanidine  have recently been found to block the 
action of acetylcholine (ACh) postsynaptically (Watanabe et al.,  1978; Farley 
et al.,  1979 a and  1979 b). Guanidine compounds are of particular interest for 
several  reasons.  First,  it  has  been  suggested  that  guanidine  is  an  important 
group of tetrodotoxin  (TTX)  and saxitoxin  (Hille,  1975; Ritchie and Rogart, 
1977)  in their highly specific blocking action on the sodium channel  in nerve 
membranes (Narahashi et al., 1964). Thus, these simple guanidine compounds 
are expected to provide insight  into the molecular structure and topography 
of ionic  channels.  Second,  the  n-alkyl  derivatives  form  a  simple  structure- 
activity series, the only differences between these derivatives being the length 
of the alkyl side chain. Third, at least one of the compounds, methylguanidine, 
is  clinically significant.  During  renal  failure  many  neuropathological  symp- 
toms occur which may be correlated with the accumulation  of methylguani- 
dine (Giovannetti et al.,  1969). 
The  present  study  is  concerned  with  the  mechanism  by  which  n-alkyl 
guanidine  derivatives block the postsynaptic action of ACh.  We have found 
that the ionic channels, but not the ACh receptors of the endplate membrane, 
are blocked by the n-alkylguanidine compounds. The potency and character- 
istics of the blocking action are a function of the length of the alkyl side chain. 
Both the open and the closed channel  are affected by these compounds. 
METHODS 
The sartorius and cutaneous pectoris muscle preparations  from the frog Rana pipiem 
were  used.  Southern  frogs  were  obtained  from  Texas  and  maintained  at  room 
temperature in a  tank with cold running water. The muscles were pinned out in a 
Plexiglas chamber. The nerves were isolated and stimulated via a suction electrode. 
The bath was continuously perfused with Ringer's solution. Muscle contraction was 
eliminated  by treating the preparation  with  formamide, a  technique developed by 
del  Castillo  and  de Motta  (1977).  The  muscle was treated  for 25-35  min  with  a 
Ringer's  solution  containing  2  M  formamide  and  100-500  nM  TTX.  The  TTX 
reduced  large  contractions  that  occurred  when  the  muscle  was  exposed  to  the 
hypertonic  formamide  Ringer's  solution.  The  muscle  was  then  washed  out  with 
normal Ringer's solution. At least 1 h was allowed for recovery. With this method the 
resting potential of ~ -90 mV was regularly recorded after treatment with formamide. 
Neuromuscular transmission was intact and apparently unaltered. 
The Ringer's solution used contained (mM);  115 NaC1, 5.4 KCI,  1.8 CaCl2, and 2 
N-2-hydroxethylpiperazine-N'-2-ethane sulfonic acid (HEPES). The pH was adjusted 
to 7.3 with NaOH. In some experiments d-tubocurarine or TTX was added to the 
bathing solution.  Methylguanidine  as the hydrochloride was obtained from Sigma 
Chemical Co., St. Louis, Mo. Ethyl-, propyl-, and octylguanidine as the sulfate salt 
were  synthesized  for  us  by  Dr.  John  Dutcher  of the  National  Cancer  Institute, 
Beth~da, Md. Amylguanidine was available from our own laboratory. Acetylcholine 
chloride was obtained from Sigma. 
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naUy developed by Takeuchi and Takeuchi (1959). A 5- to 10-M~ micropipette filled 
with  3  M  KCI  was  used  to  measure  membrane  potential.  The  current-injection 
micropipette  was  filled with  either  3  M  KCI  or  2  M  potassium  citrate  and  had 
resistance ranging from 2 to 5 M~. The location of the endplate was determined by 
the occurrence of miniature endplate potentials (MEPPs) with ~0.5 ms rise time. The 
voltage-measuring  and  current-injection  electrodes  were  inserted  in  the  endplate 
region within  20-30/xm of each other.  Both electrodes were shielded with metal to 
decrease interelectrode  capacitative  coupling.  The  endplate  currents  (EPCs)  were 
recorded through a virtual ground circuit connected to the bath. The rise time of a 
voltage command  pulse applied to a cell  during voltage clamp was typically <200 
/xs, and the capacitative current transient was longer, generally lasting <300/xs. 
In some experiments, acetylcholine was applied iontophoretically to the endplate. 
A short constant-current pulse (0.5-2 ms) was injected into a micropipette filled with 
1 M ACh and of 40-100 Mf~ resistance.  A small braking current was applied to stop 
diffusion of ACh from the micropipette tip. 
All experiments were performed at 20~176 
RESULTS 
Endplate Potential 
Whenever  EPPs  and  EPCs  are  used  as  a  measure  of  the  postjunctional 
blocking action,  it  must  be determined  whether  the  compound  in  question 
has any effects on the presynaptic elements.  It is well known that  guanidine 
itself increases transmitter release at the neuromuscular and synaptic junctions 
of the frog, rat,  and squid  (Otsuka and Endo,  1960; Teravainen  and Larsen, 
1975;  Kusano,  1970).  The  shorter  chain  n-alkyl  derivatives  of guanidine, 
methyl-, ethyl-, and propylguanidine have also been found to exert this action 
(Farley et al.,  1979 a).  Methylguanidine  at  a  concentration  of 5 mM greatly 
increased the endplate potential  amplitude,  as shown in Fig.  1. The increase 
in  EPP  amplitude  took 30  min  to  reach  a  steady state.  When  the  methyl- 
guanidine  was  washed  out,  there  was  initially  a  further  increase  in  the 
amplitude of the EPP (Fig. 1 C). This suggests that two processes are occurring, 
one that  increases EPP amplitude  (presynaptic)  and one that  decreases EPP 
amplitude  (postsynaptic).  Extended washing decreased the amplitude of the 
EPP to the control level (Fig.  1 D). Complete reversal of the increase in EPP 
amplitude required 60-90 min of washing.  Methyl-, ethyl-, and propylguan- 
idine  all  affected  the  EPP  in  a  similar  manner.  All  of these  compounds 
decreased the amplitude of MEPPs and abolished them completely at higher 
concentrations.  This  observation  is  also  compatible with  their  postsynaptic 
blocking action. 
The longer-chain  derivatives of guanidine,  amyl- and octylguanidine, have 
no apparent  presynaptic action (Farley et al.,  1979 a). That the shorter-chain 
alkyl derivatives affect transmitter release will be considered when the effects 
of these compounds on the time-course of the EPC are discussed. 
The guanidine  derivatives had no effect on the membrane potential of the 
muscle, with the exception of octylguanidine,  which consistently caused the 
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Dose-Response Relation 
The effectivenss of n-alkylguanidines  to block the postsynaptic action of ACh 
was measured by determining the dose-response relationship  for inhibition  of 
the iontophoretically induced ACh potential. These responses were obtained 
at resting potentials of-85  to -95  mV and typically had rise times between 
10 and 30 ms. The amplitude of the responses varied from  10 to  15 mV. The 
dose-response curve for the effect of octylguanidine  on the amplitude  of the 
ACh  potential  is shown in  Fig.  2 A.  The  effective dose 50  (EDso)  values for 
endplate block were estimated  to be 4  mM,  0.4 mM,  65 #M, and  6 ptM  for 
ethyl-, propyl-, amyl-, and octylguanidine, respectively. These data are shown 
graphically in Fig. 2 B, in which the logarithm  of the EDs0 values are plotted 
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FIGURE  I.  The effects of 0.5 mM methylguanidine on endplate potential.  (A) 
Control.  (B)  After  a  10-min  exposure  to  solution  containing  5  ￿  10  -a  M 
methylguanidine.  (C)  After wash-out  of methylguanidine  for 3  min.  Note a 
further increase in amplitude. (D) Reversal of methylguanidine's effects after 60 
min of washing. 
against  the  number  of carbons  in  the  alkyl  side chain.  Clearly,  there  is  an 
increase  in  potency  as  the  side  chain  is  lengthened.  This  increase  may  be 
attributed  to either molecular size or hydrophobicity.  This will be discussed 
below. 
The  block  of the  endplate  could  occur  either  at  the  channel  or  at  the 
receptor. To distinguish between these two possibilities, a  "protection" exper- 
iment was performed. 
Protection Experiments 
If a  compound  binds  to  the  ACh  receptor,  a  high  concentration  of that 
compound  should  protect  the  receptor  from  binding  by  a  highly  specific, 
irreversible  antagonist  such  as  a-bungarotoxin  (ot-BuTX)  (Chang  and  Lee, FARLEY ET AL.  Endplate  Channel  Block by Guanidine Derivatives  277 
1963).  Such a  protection of the receptor from a-BuTX block demonstrates 
that the compound binds to the receptor. The following protocol was used to 
determine whether methyl- or octylguanidine could protect the receptor from 
~-BuTX binding. The muscle was incubated in 20 mM methylguanidine or 
180 ~M octylguanidine for 30  min before and during a  20-min exposure of 
the muscle to 0.05-0.2 #g/ml a-BuTX. Higher concentrations of octylguani- 
dine caused an irreversible damage to the muscles. After washout of all the 
drugs,  nerve stimulation  failed  to  induce action  potentials  or  EPPs  in  the 
surface fibers.  The blocking action of 20  mM methylguanidine or  180  #M 
octylguanidine applied alone for the same length of time was reversible upon 
washing. In similar experiments, 100/~M d-tubocurarine protected the receptor 
from  block  by  a-BuTX,  because  after  washing  large  EPPs  and/or  action 
potentials could be observed. 
These findings suggest that the n-alkylguanidine derivatives do not bind to 
the receptor but block the channel. Further evidence in favor of a  channel- 
blocking mechanism has been obtained by characterizing the EPC blocking 
action. The characteristics of the EPC block are not consistent with receptor 
block. 
Decay of Endplate Current 
The guanidine derivatives had a marked effect on the EPC time-course. Four 
families of EPCs are shown in Fig. 3. The EPC family on the left was obtained 
in normal Ringer's solution at membrane potentials ranging from -  100  to 
+  40  mV  in  20-mV steps.  The EPC  was elicited  10  s  after the membrane 
potential was stepped to a new potential from -50 inV. The amplitude of the 
control EPCs was approximately a linear function of the membrane potential. 
The decay of the EPCs could be described by a  single exponential function, 
and the rate of decay was dependent on the membrane potential, becoming 
faster as  the membrane was  depolarized.  In  the presence of the guanidine 
derivatives, these characteristics were markedly altered. 
All  the  derivatives  used  inhibited  inward  endplate  currents  more  than 
outward currents.  The short  chain  derivatives methyl-, ethyl-, and  propyl- 
guanidine  caused  the  inward  currents  to  decay  faster,  while  the  outward 
currents were prolonged. The time-course of decay remained approximately 
exponential.  However, a  slight  nonlinearity of the decay, especially that  of 
outward  EPCs,  was  observed  when  they were  plotted  on  semilogarithmic 
coordinates. The nonexponential decay may arise from the effect of propyl- 
guanidine  on  transmitter  release.  An  example  of  EPCs  obtained  in  the 
presence of 1.7 mM propylguanidine from the same endplate as in Fig. 3 A is 
shown in Fig. 3 B. Note that the outward currents in Fig. 3 B are larger than 
those in the control. This is caused by the presynaptic action of this compound 
to stimulate transmitter release. The effects of 0.26 mM amylguanidine on the 
EPC  decay shown in  Fig.  3  C are quite different from those of the shorter- 
chain  derivatives.  Amylguanidine prolonged  the  inward  EPCs  and  caused 
them to decay in a  biphasic manner. In contrast, the outward currents were 
prolonged but decayed as a single exponential. These currents were obtained 278 
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at membrane potentials ranging from -100 to +50 mV. In the presence of 18 
/xM  oetylguanidine  (Fig.  3  D),  the  EPCs  decayed  faster  and  with  a  single 
exponential  time-course  at  all  potentials.  The  membrane  potential  ranged 
from -90 to +70 mV in 20-mV steps for the currents shown. 
The  time  constant  of  decay  ('r) of  the  normal  EPC  changes  with  the 
membrane potential, depolarization decreasing the time constant. The voltage 
dependence of the rate of decay is  described by the equation  ~" -- r  (0)  exp 
(-0.011  ￿  Era),  where  Em  denotes  the  membrane  potential.  This  voltage 
dependence is similar  to that  observed by Magleby and  Stevens  (1972)  and 
by Ruff (1977). In the presence of 2.6 mM propylguanidine,  the dependence 
of ~" on voltage was reversed such that as the membrane was depolarized, the 
currents were prolonged  (Fig.  4 A). A  similar effect was also observed in the 
A  B  C  D 
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FIGURE 3.  Families  of EPC  recorded  at  various  membrane  potentials.  The 
family on the left (A) was obtained in control solution and the other families (B, 
C,  and  D)  in  the presence of the compounds shown.  Records A and  B were 
obtained at the same endplate. Each EPC was elicited 10 s after a step change 
of the membrane potential. 
presence of methyl- and ethylguanidine.  Because of the effect on transmitter 
release, it is difficult to quantify the purely postsynaptic action of short-chain 
guanidine derivatives on the EPC decay. 
The  decay  of the  inward  EPCs  in  the  presence  of amylguanidine  was 
biphasic (Fig. 3 C). Amylguanidine had no apparent presynaptic action. The 
FIGURE 2.  (A) Dose-response curve for the inhibition of the iontophoretically 
induced ACh potential by octylguanidine obtained at membrane potentials of 
-85  to  -95  inV.  The  data  represent  the  mean  "!"- SEM  of at  least  three 
experiments.  The  inset is  typical  iontophoretic  acetylcholine responses before 
and during the wash-in of 9.1 #M octylguanidine. The scales are 40 ms and 5 
mV.  (B)  The  EDs0  values  for  the  inhibition  of  iontophoretically  induced 
acetylcholine potentials by the n-alkylguanidine compounds plotted against the 
number of carbons in the alkyl side chain. The points are means of at least three 
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decay of the inward EPCs in the presence of amylguanidine  could be separated 
into the sum of two exponential components by curve stripping. In Fig.  4 B, 
the voltage dependence of the time constant of the slow  (squares)  and fast 
(triangles) components of decay in the presence of 0.13 mM amylguanidine is 
illustrated together with the control (circles). In the presence ofamylguanidine 
the EPCs decay more slowly than in the control solution at all potentials, as 
is shown by the slow component. However, the slope for the voltage depend- 
ence of the slow phase of the EPC decay in 0.13  mM amylguanidine is less 
than the control. The voltage dependence of the slow phase of EPC decay can 
be described by the equation ~'slow -- z(0)~ow exp (-0.0047 ￿  Era). Amylguan- 
idine prolonged the currents more at  a  concentration of 0.26  than  at  0.13 
mM.  The  voltage  dependence of decay remains  similar,  however,  and  is 
described by  the  equation  ~'~ow --  r(0)~aow exp  (-0.0045  ￿  Em). The  fast 
component of the EPC decay in 0.13 and 0.26 mM amylguanidine  consistently 
had  a  voltage dependence reversed from that  of the slow decay. However, 
there is a  considerable error involved in obtaining the time constant of the 
fast component. 
Octylguanidine caused the EPCs to decay faster at all potentials (Fig. 3 D). 
The rate of decay was increased as the concentration of octylguanidine was 
raised as is shown in Fig. 5 A for 9.1 and 27.3 #M. The voltage dependence of 
the decay was reduced by octylguanidine, although it can still be described by 
a single exponential function. The decrease in the voltage dependence of the 
decay was dependent on the concentration of octylguanidine. In 9.1 and 27.3 
/~M octylguanidine, the decay is described by the equations, ~" -  ~"  (0)  exp 
(-0.0051)  X Era) and "r =  z (0) exp (-0.0028 X Era), respectively. Octylguan- 
idine at a concentration of 1.8 #M only slightly affected the EPC decay and 
did not alter the voltage dependence of ~" appreciably. However, it caused a 
33% reduction of the peak EPC amplitude at -90 mV. 
If the  channel  blocking  action  of octylguanidine is  a  pseudo-first-order 
process, then a plot of the decay rate of the EPC against the concentration of 
octylguanidine should yield a  straight line, the intercept being equal to the 
normal EPC  decay rate and the slope to  the rate at  which octylguanidine 
blocks the channel (Adams,  1976). Such plots are shown in Fig.  5 B for the 
decay of EPCs at -90, -50, and +50 mV. The lines through the points are 
drawn by least square fits. The correlation coefficients for the fits are 0.971, 
0.965,  and  0.929,  respectively. The  linearity of this  plot  suggests  that  the 
kinetics of the block of the endplate channels by octylguanidine are consistent 
with a pseudo-first-order process and that the dissociation (unblocking) rate 
is negligibly low. The slopes of the lines are 5.0 X  10 7 M -I s  -1 at -90 mV, 5.4 
X  10  v M -1 s  -1 at -50 mV, and 4.6  x  107 M -I s  -1 at  +50 mV. The rate of 
block is not significantly voltage dependent. 
Current- Voltage Relationship 
It  has  been  shown  that  the  magnitude of the  channel block  caused by a 
number of compounds such as procaine, QX-222, histrionicotoxin, amanta- 
dine, and decamethonium is dependent on the membrane potential (Kordas, 
1970; Deguchi and Narahashi,  1971; Ruff,  1977; Masukawa and Albuquer- 281 
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que,  1978; Tsai  et  al.,  1978; Adams  and  Sakmann,  1978).  We  have  also 
observed  that  the  magnitude of the  EPC  block  caused  by  the  guanidine 
derivatives is dependent on the membrane potential. 
All the n-alkylguanidine derivatives used  in this study caused the  EPC- 
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FIaURE 4.  Logarithm of the  time constant  of EPC  decay  (~') plotted  as  a 
function of membrane potential in control solution (O) and in the presence  of 
2.6 mM propylguanidine (0).  Note that the voltage dependence of the EPC 
decay is  reversed  by propylguanidine. These data were obtained at  a  single 
endplate. (B) The effect of 0.13 mM amylguanidine. The logarithm of the time 
constant  of decay  (,)  is  plotted  against  membrane  potential.  Open  circles 
represent measurements in control solution, and the triangles and squares are 
the fast  and slow components in 0.13 mM amylguanidine, respectively.  The 
measurements are the means +  SEM of six experiments. 
voltage (I-V)  relationship to become extremely nonlinear under certain con- 
ditions  (Fig.  3).  It  was observed,  however, that  the shape of the I-V curve 
obtained in the presence of  octylguanidine differed, depending on the protocol 
used. This is illustrated in Fig. 6 A. The open circles represent the control I-V 282  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  77  -  1981 
relationship obtained 5  ms after each  2.2-s  potential step  from the holding 
potential of -50 inV. The control/- V curve is approximately linear, regardless 
of the  time  at  which  it  is  obtained  after  the  beginning  of voltage  step. 
However, in the presence ofoctylguanidine,  the curve was different, depending 
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FIOURE 5.  (A) The effect of octylguanidine on the voltage dependence of EPC 
decay time constant  0%  The  open  circles  are  the  measurements in  control 
solution. The filled circles and triangles represent the effect of 9.1 and 27.3 #M 
octylguanidine, respectively.  The data were obtained at a single endplate. (B) 
The rates of EPC decay (1/r  as a function of the concentration of octylguani- 
dine. The data were obtained at membrane potentials of-90 (O), -50 (A), and 
+50 mV (R). The lines are least square fits to the data. The data represent the 
means •  SEM of at least three experiments. 
on when an EPC is elicited after the beginning of each potential step. The L 
V curve  obtained  5  ms  after  each  potential  step  is  linear  (closed  circles), 
whereas  the  I-V  curve  obtained  2  s  after  each  step  is  highly  nonlinear 
(triangles). We envisage that the block of peak EPC measured 5 ms after the FARLEY ET AL.  Endplate  Channel Block by Guanidine Derivatives  283 
potential step represents the sum of open-channel block associated with each 
potential step and the closed-channel block at -50 mV. The block measured 
at 2 s represents the sum of open- and closed-channel block at each potential 
step.  That  the /-V curve obtained  5  ms  after each  potential  step  is  linear 
suggests the open channel block is  voltage independent.  It  is  interesting to 
note that the EPCs obtained 5 ms after the potential step exhibit less inhibition 
than those at  2  s at  membrane potentials  more negative than  -50  inV.  At 
positive  membrane  potentials  the  opposite  relationship  holds.  The  results 
strongly suggest that the closed-channel block is highly voltage dependent. 
Block Development and Recovery 
The time-course of block development was determined by eliciting an EPC at 
various times after the beginning of a  2-s  voltage step.  The.membrane was 
held  at  -50  mV  for  8  s  between  these  episodes.  This  time  interval  was 
determined to be adequate for full recovery at -50 mV. When the membrane 
was hyperpolarized from -50 mV, there was a time-dependent increase in the 
blocking action of 10 pM octylguanidine, as shown in Fig. 6 B for membrane 
potentials of-70  and -90 mV. 
The half-time of block development ranged from 200  to  500  ms with no 
clear voltage dependence. However, the steady-state level of block was highly 
voltage dependent. For example, at membrane potentials of-  110,  -90, and 
-70  mV, the ratios of steady-state (i.e., at  2 s)  to initial  (i.e., at 5  ms)  EPC 
amplitude  were 0.2,  0.4,  and 0.7,  respectively. Such  voltage  dependence is 
reflected in  the /-V relationship as the difference obtained at  5  ms and  2  s 
after the voltage step. 
When  the  membrane was  depolarized  from  -50  to  +30  mV  in  10  /xM 
octylguanidine,  a  time-dependent  removal  of block  was  observed.  This  is 
illustrated in Fig. 6  C. The half-time of recovery at +30 mV is 500-600  ms, 
and the ratio of steady-state to initial  EPC  amplitude ranges from  1.5  to  2. 
This removal of block is reflected in the I-V curves (obtained at 2 or 10 s) at 
membrane potentials positive to -50 mV (Fig. 6 A). 
Amylguanidine  (200  #M)  also  induced  a  time-dependent  block,  which 
developed with  a  half-time of ~300  ms at  -100  and  -90  mV.  Thus,  both 
amyl- and octylguanidine block the channel in  a  highly voltage-dependent 
manner independent of channel opening. 
DISCUSSION 
The potency and characteristics of the blocking action of the n-alkyl derivatives 
of guanidine  vary with  the  length  of the side chain.  Methyl-, ethyl-, and 
propylguanidine cause  inward  EPCs  to  decay faster but  prolong  outward 
EPCs, similar to the action of amantadine (Tsai et al.,  1978).  Amylguanidine 
prolongs the inward currents and causes them to decay biphasically. Outward 
currents are also prolonged, but the decay can still be described by a  single 
exponential  function.  These  effects  are  similar  to  those  of  QX-222  and 
procaine (Ruff,  1977;  Kordas,  1970;  Deguchi and Narahashi,  1971;  Adams, 
1977).  Octylguanidine causes both inward and outward EPCs to decay faster, 284 
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FIaURE O.  (A)  Current-voltage  relationships  obtained  from  the control  end- 
plate  (￿9  and  in  the  presence  of  10  #M  octylguanidine  (0  and  i).  The 
measurements  represented  by  the  closed  and  open  circles  were  obtained  by 
eliciting a  single EPC 5 ms after the beginning of a  2.2-s voltage step, and the 
closed  triangles by elieiting an  EPC  2  s after the voltage step.  (/7) The time- 
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and the decay time-course remains single exponential. This is similar to the 
action of Q.X-314. All of the guanidine derivatives cause a marked nonlinearity 
of the current-voltage relationship, indicating that the block is voltage depen- 
dent. A nonlinear current-voltage relationship is also observed in the presence 
of local anesthetics, amantadine and histrionicotoxin (Deguchi and Narahashi, 
1971;  Tsai  et  al.,  1978;  Masukawa  and  Albuquerque,  1978),  although  in 
general the nonlinearity of the current-voltage relationship is not as great as 
that observed for the n-alkylguanidines. 
The  n-alkylguanidine  derivatives  present  an  excellent  structure-activity 
relationship from which information about  channel blocking action can be 
obtained. The obvious structural difference between these compounds is the 
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length of the alkyl side chain. It is also clear that the alkyl side chain affects 
the potency and kinetics of drug action. The blocking potency is enhanced by 
lengthening the side chain. 
The relationship is similar to those observed for the block of sodium and 
potassium channels by quaternary ammonium derivatives (Rojas and Rudy, 
1976;  Shoukimas  and  French,  1979).  These  authors  concluded  that  the 
observed increase in potency was related to the increase in side-chain hydro- 
phobicity.  This  conclusion  also  seems reasonable  as  an  explanation  of the 
plotted as a function of the time (At) after the beginning of a 2.2-s voltage step 
from -50 to -70 mV (O) or to -90 mV (O). Only one EPC is elicited during 
each step.  (C)  The time-course of the removal of octylguanidine block.  The 
protocol is similar to B except the potential step is from -50 to +30 mV. 286  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  77 ￿9 1981 
increase  in  potency with  side-chain length in  the alkylguanidine series.  In 
support of this idea, the standard free-energy change of the blocking reaction 
for each methylene added can be calculated from the data on the effect of 
chain length on potency of the derivatives. One-to-one binding was assumed, 
and the EDs0 values were used as estimates of the dissociation constant. The 
change in standard free energy is estimated to be 560 cal/mol of methylene. 
The theoretical free-energy change per methylene transferred from an aqueous 
to a  hydrophobic environment is  ~1,000 cal  (Kauzmann,  1959).  It is note- 
worthy that free-energy change per methylene for the interaction of n-alkyl- 
guanidine with the sodium channels of Electrophorus electricus (Reed and Trzos, 
1979) and that of squid axons (Kirch et al.,  1980) were found to be 590 and 
650 eal, respectively. Rojas and Rudy (1976)  also determined a  similar free- 
energy change per methylene for interaction of tetraethylammonium deriva- 
tives with the sodium channels of squid. 
The length of the alkyl side chain also alters  dramatically the effects of 
these compounds on EPC amplitude and kinetics. These changes may arise 
from differences in their kinetics of interaction with the channels. It has been 
proposed  that  compounds such  as  QX-222  and  QX-314  can  bind  to  the 
channel only when it is open (Ruff, 1977;  Neher and Steinbach,  1978).  This 
is schematically represented by 
c 
CLOSED ~  OPEN ~  BLOCKED,  (Scheme 1) 
a  F 
where CLOSED is the ACh bound receptor, channel nonconducting, OPEN 
the  ACh  bound  receptor,  channel  conducting,  BLOCKED  the  open  but 
blocked state of channel, and G, F, a, and fl the rate constants for the various 
reaction steps. The actions of the n-alkylguanidines will be compared with the 
predictions of this model. 
One prediction of this model is that the amplitude of the EPC will only be 
reduced if there are alterations  in the EPC kinetics.  Both amyl- and octyl- 
guanidine decrease EPC amplitude before they measurably alter EPC decay. 
For example, at  1.8 #M, octylguanidine reduces EPC amplitude by 33%  (at 
-100 mV) but has no effect on EPC kinetics. Preliminary results from noise 
analysis suggest that amylguanidine decreases the amplitude of the iontopho- 
retically induced ACh current before it alters channel kinetics. 1 
A  second prediction of this model is that if the rate of dissociation of the 
blocking compound from the channel is slow (as suggested for octylguanidine), 
iontophoretically induced ACh responses will be inhibited to a greater extent 
than will the EPC. However, octylguanidine reduces the EPC and iontophor- 
etic ACh response to a similar degree. This suggests a process that affects the 
amplitude of the postjunctional response independent of the kinetics of that 
response. 
Another feature of the sequential model is that the channel must be opened 
before it can be blocked. However, it is clear that amyl- and octylguanidine 
1 Farley, J. M., and C.  H. Wu. Unpublished observation. FARLEY ET AL.  Endplate  Channel Block by Guanidine Derivatives  287 
can block  the channel in  the absence of channel activation.  This  block  is 
highly voltage  dependent and  develops or  is  relieved with  a  half-time of 
several hundred milliseconds after a  hyperpolarizing or depolarizing voltage 
step.  Therefore,  the  sequential  blocking  mechanism does  not  adequately 
describe the action of these compounds. 
To further substantiate this idea, we have simulated EPCs using the model 
of Magleby and Stevens (1972) with the added feature that EPC kinetics can 
be modified by the action of channel blockers. To do this we incorporated the 
simple sequential blocking mechanism into their model. 
Fig.  7 A is a  family of computer-generated normal EPCs.  These currents 
were generated by assuming that the driving function used by Magleby and 
Stevens (1972) had exponential rising and falling phases with 0.1- and 0.2-ms 
time constants, respectively, and that the reversal potential for the EPC was 
-5 mV. The rate of decay of the EPC was calculated from the equation 1/'r 
--  1.6 ￿  10  a exp (0.0083  ￿  Era) s  -1. Fig.  7 B shows a family of EPCs obtained 
from a  voltage-clamped endplate. The model simulates the observed EPCs 
quite satisfactorily. The EPC in QX-222 and QX-314 were also adequately 
simulated by this model as well as the voltage dependence of their blocking 
action. The rate constants for the block and unblock of channels by QX-222 
and QX-314 were taken from Neher and Steinbach (1978). 
Octylguanidine was found to block EPCs by a pseudo-first-order reaction. 
The EPCs decay faster than in the control at all potentials in the presence of 
octylguanidine. The  forward rate  constant  (G)  for  the  block  of EPCs  by 
octylguanidine is estimated to be in the range of 4-6 ￿  107 M -1 s  -1, which is 
slightly  larger  than  that  for QX-222  and  QX-314  (Neher and  Steinbach, 
1978) but is of the same order of magnitude. The forward rate constant of 
block for octylguanidine is not voltage dependent, which is different from the 
effects of QX-222  (Neher and Steinbach, 1978; Ruff, 1977). To simulate the 
effect of octylguanidine on EPCs, a forward rate constant of 5 ￿  107 M -1 s  -1 
was used, and the reverse rate constant (F) was assumed to be much smaller 
than  G,  in  this  case  0.01  s  -1  for  octylguanidine. This  assumption  seems 
reasonable, because the blocking action ofoctylguanidine  follows pseudo-first- 
order kinetics. The currents predicted from these kinetic data are shown in 
Fig. 8 A for 9.1/~M octylguanidine. A family of EPCs experimentally obtained 
in the presence of 9.1 ~M octylguanidine is shown in Fig. 8 B. The time-course 
of the currents in the presence of octylguanidine is simulated well, the decay 
rate being increased at all  membrane potentials. This model also simulates 
the linear current-voltage relation for peak EPC  measured 5  ms after each 
potential  change (see  Fig.  6  A),  which probably represents the sum of the 
open-channel block at various potentials and the closed-channel block at -50 
mV.  However, the  magnitude and  voltage dependence of the  steady-state 
block of peak currents measured at 2-10 s (Fig.  6 A) are obviously not well 
simulated by the model. The blocking potency and voltage dependence of the 
blocking action are greatly underestimated. For example, at  -100  mY, 9.1 
/~M octylguanidine reduces the EPC amplitude by ~75%, whereas the model 
predicts only an ~ 10% reduction in amplitude. This vast difference  is probably 
attributable to the closed-channel block shown in Fig. 6 A. 288  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  77  -  1981 
Amylguanidine  causes inward  currents  to decay in  two exponential  func- 
tions. Such alterations in EPC time-course can be predicted by the sequential 
model  (Adams,  1976;  Ruff,  1977;  Neher and Steinbach,  1978). Therefore, as 
a  first  approximation,  we  assume  that  the  alterations  in  EPC  decay  arise 
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FIGURE  7.  (A)  Computer  simulation  of an  EPC  family using  the  model  of 
Magleby and Stevens (1972). (B) An EPC family recorded at a voltage-clamped 
endplate (control). The membrane potential ranged from -100 to +40 mV in 
20-mV steps for each family. See the text for further explanation. 
mainly from open-channel  block. If this is true then the forward and reverse 
rate constants can be estimated  from the fast and slow rates of decay of the 
inward  EPC  by the  relationships  derived  by Adams  (1976),  Beams  (1976), 
and  Ruff (1977).  In the case of amylguanidine,  the forward and reverse rate FARLEY ET AL.  Endplate  Channel Block by Guanidine Derivatives  289 
constants  of  block  are  estimated  to  be  "--3  X  l0  s  M -1  s  -1  and  103  s  -i, 
respectively, at -100 mV. The forward rate constant for octylguanidine block 
is estimated to be on the order of 4-6 X  l0  T  M -x s  -1. The reverse rate constant, 
however, has to be much smaller in this case to obtain a  single exponential 
decay and is assumed to be on the order of 0.01  s  -x.  Thus, the length of the 
alkyl side chain apparently affects rate constants of the blocking reaction. The 
reverse  rate  constant  appears  to  be  greatly  decreased  as  the  side  chain 
lengthens and the forward rate constant increases somewhat. Thus, the longer 
side-chain derivative comes off the channel much more slowly than does the 
shorter side-chain derivative. 
However,  it  should be  noted  that  the  rate  constants determined for the 
blocking action of amylguanidine will not even qualitatively predict the time- 
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FmURE 8.  (A) Computer simulation of an EPC family in the presence  of 9.1 
~M octylguanidine assuming that it only interacts with the open channel. (B) 
An EPC family recorded at a voltage-clamped endplate in the presence  of 9.1 
#M octylguanidine. The membrane potential ranged from -100 to +40 mV in 
20-mV steps. The current traces at -100 and -80 mV overlap. 
course of the inward EPC altered by amylguanidine. To generate two expo- 
nential decay phases it is necessary to have a  forward rate constant of ~107 
M -1 s  -1. The reverse rate constant should be <104 s  -x. Rate constants similar 
to these were estimated for the action of QX-222, which is known to cause the 
EPC to decay as the sum of two exponential functions (Ruff, 1977;  Neher and 
Steinbach, 1978).  An underestimate of the forward and reverse rate constants 
in the presence of amylguanidine could arise from two sources. First, the fast 
decay phase  of the  EPC  is  small, and thus  the rate of decay is  difficult to 
extract.  Second,  the  transmitter  release  function  may  alter  the  fast  rate 
constant of decay. 
The outward currents in amylguanidine cannot be simulated adequately. 
To describe the fast and slow components of EPC decay, we made calculations 290  XHE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  77  ￿9  1981 
using our computer simulations and the equations derived by other investi- 
gators  (Adams,  1976;  Beams,  1976;  Ruff,  1977).  We presume that this slow 
decay of outward EPC arises from the same reaction scheme as that producing 
the slow inward EPC decay and that  the initial  fast  component of EPC  is 
indiscernible because of the fast dissociation constant, F. Thus, the outward 
EPC exhibits a single exponential decay. The sequential model will predict a 
prolongation of the EPC up to 2.5 times that of the control. 
The time-course of EPC could be affected in other ways.  For example, a 
drug could alter transmitter release, affect acetylcholinesterase activity (Gold- 
ner and  Narahashi,  1974;  Magleby  and  Terrar,  1975),  or change the  rate 
constant of channel closure, a  (Gage et al.,  1978).  However, amylguanidine 
has  no  effect  on  acetylcholinesterase  activity  2  and  on  transmitter  release 
(Farley et al.,  1979 a). It is not known whether the rate of channel closing is 
affected by amylguanidine. 
Thus, it would seem that the sequential model, in its simplest form, cannot 
adequately predict the time-course of EPC altered by amylguanidine. As with 
octylguanidine, it is difficult to simulate the magnitude and voltage depend- 
ence of the block. 
These findings suggest that the mechanisms by which amyl- and octylguan- 
idine block the endplate channels cannot be totally described by the simple 
sequential  model  shown  in  Scheme  1  for  the  action  of local  anesthetics. 
Another mechanism of block must  also be considered to explain  the large 
vohagc dependence and magnitude of the block. As suggested previously, it 
is possible that the alkylguanidines may also affect the closed channel such 
that it does not open or, if opened, that its conductance is greatly decreased. 
This is similar to "resting block" in the sodium channels in nerve. The closed- 
channel block must also be voltage dependent to explain the voltage depend- 
ence of the block that we have observed. 
Adams  (1977)  has proposed that  procaine blocks the resting state of the 
endplate ionic channel through a cyclic mechanism. The voltage dependence 
of this block was not determined, although it was suggested that it is less than 
that for block of the open channel. Masukawa and Albuquerque (1978)  have 
shown that the block of the endplate channel by histrionicotoxin is vohagc 
dependent and that part of the blocking action can occur in the absence of 
receptor  activation.  Thus,  histrionicotoxin also  acts  by  a  mechanism  that 
could be termed resting or closed-channel block. This type of block is inten- 
sified as the membrane is hyperpolarized. Tetraethylammonium has also been 
shown to have a  similar blocking action on the closed channel (Adler et al., 
1979). 
The  10-fold difference in potency between amyl- and octylguanidine may 
be caused in part by differences in their ability to block the closed channel. It 
is unclear whether or not the shorter chain derivatives can block the closed 
channel, because transmitter release is increased at the same concentrations at 
which the EPC is blocked (Farley et al.,  1979 a).  It would be interesting to 
2  Phillips, T., J. M. Farley, and A. M. Boyne. Unpublished observation. FARLEY ET AL.  Erdplate Channel Block by Guanidine Derivatives  291 
determine whether the  amount  of closed channel  block is  a  function of the 
alkyl side-chain length. 
The lack of voltage dependence of the forward rate and of the magnitude 
of the  proposed  open-channel  block by octylguanidine suggests  that  it  does 
not penetrate far into the potential field of the membrane when blocking the 
channel. On the other hand, the large voltage dependence of closed channel 
block (Fig. 6 A)  suggests that a  large fraction of the membrane field must be 
crossed to reach the blocking site. This implies that two separate blocking sites 
exist, one near the mouth of the channel and the other well into the membrane 
field.  However, we cannot  rule out the possibility that  octylguanidine binds 
to a  single site because the voltage profile across the channel could differ for 
the closed and the open configurations. 
Adams  (1977)  has  proposed  that  procaine blocks  the  ACh  channel  by  a 
cyclic mechanism  in  which  procaine  could  reach  the  same  blocking  site  in 
both the closed and the open channel by separate pathways.  Hille (1977)  has 
proposed  that  two  pathways  exist  for the  block of the  open  and  the closed 
sodium  channel  of nerve  membranes  by  local  anesthetics.  Thus,  it  is  also 
plausible  that  two  separate  pathways  exist  for  the  channel  block  by  alkyl- 
guanidines. 
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